Lumida
/ORKA
⌘K
Oruka Therapeutics Inc

Oruka Therapeutics Inc

ORKA
$92.38USD+0.80%+0.73 today

MARKET CAP

6.1B

P/E (TTM)

FWD P/E

DAY RANGE

$90 – $94

52W RANGE

$15
$116

AI Summary

Stalk
TrimMedium

ORKA is in a Stage 3 distribution phase marked by a bearish pivot failure and EMAs crossed below the 50-SMA, signaling downward mean reversion. The medium-term bias is bearish, and any rally into the 9/20/50‐SMA resistance zone near $93–$95 should be faded. Short-term conditions are neutral rather than opportunistically bearish, so execution is deferred until a sign of rejection at dynamic resistance. The long-term uptrend above the rising 200-SMA remains intact but is currently overshadowed by structural distribution.

  • Phase 2a trial showed 63.5% of psoriasis patients reached complete clearance
  • Shares jumped 21.95% over two weeks, hitting a $109.56 52-week peak
  • Balance sheet shows high leverage risk that could restrict flexibility
Full analysis →
Insider Trades26 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Aug 17, 2026SellORKAJoana GoncalvesChief Medical Officer14,000$59.58$6.1B-20.03%+529.94%$834.1K+0.00%10b5-1Stalk
Aug 14, 2026SellORKAPaul T QuinlanGeneral Counsel104,000$60.04$6.1B-20.03%+529.94%$6.2M+0.00%10b5-1Stalk
Aug 13, 2026SellORKAArjun AgarwalSenior Vice President, Finance20,000$61.17$6.1B-20.03%+529.94%$1.2M+0.00%10b5-1Stalk
Jul 15, 2026SellORKAJoana GoncalvesChief Medical Officer14,000$46.80$6.1B-20.03%+529.94%$655.2K+0.00%10b5-1Stalk
Jul 13, 2026SellORKAArjun AgarwalSenior Vice President, Finance19,998$50.16$6.1B-20.03%+529.94%$1.0M+0.00%10b5-1Stalk
Jul 1, 2026SellORKALaura Lee SandlerChief Operating Officer10,000$51.11$6.1B-20.03%+529.94%$511.1K+0.00%10b5-1Stalk
Jun 22, 2026SellORKAArjun AgarwalSenior Vice President, Finance1,587$80.95$6.1B-20.03%+529.94%$128.5K-4.82%10b5-1Stalk
Jun 15, 2026SellORKALaura Lee SandlerChief Operating Officer600$69.69$6.1B-20.03%+529.94%$41.8K-0.25%Stalk
Jun 15, 2026SellORKAPaul T QuinlanGeneral Counsel733$69.69$6.1B-20.03%+529.94%$51.1K-2.31%Stalk
Jun 15, 2026SellORKALawrence Otto KleinChief Executive Officer1,729$69.69$6.1B-20.03%+529.94%$120.5K-0.19%Stalk
Jun 15, 2026SellORKAJoana GoncalvesChief Medical Officer14,947$40.27$6.1B-20.03%+529.94%$601.8K-0.16%10b5-1Stalk
Jun 12, 2026SellORKAArjun AgarwalSenior Vice President, Finance19,313$43.35$6.1B-20.03%+529.94%$837.2K-0.13%10b5-1Stalk
May 18, 2026SellORKAArjun AgarwalSenior Vice President, Finance18,123$45.99$6.1B-20.03%+529.94%$833.4K-0.80%10b5-1Stalk
May 15, 2026SellORKAJoana GoncalvesChief Medical Officer14,000$34.58$6.1B-20.03%+529.94%$484.2K+0.00%10b5-1Stalk
May 1, 2026SellORKALaura Lee SandlerChief Operating Officer10,000$35.84$6.1B-20.03%+529.94%$358.4K+0.00%10b5-1Stalk
Apr 15, 2026SellORKAJoana GoncalvesChief Medical Officer14,000$36.72$6.1B-20.03%+529.94%$514.1K+0.00%10b5-1Stalk
Mar 16, 2026SellORKAArjun AgarwalSenior Vice President, Finance395$41.30$6.1B-20.03%+529.94%$16.3K-2.05%Stalk
Mar 16, 2026SellORKALaura Lee SandlerChief Operating Officer600$41.30$6.1B-20.03%+529.94%$24.8K-0.25%Stalk
Mar 16, 2026SellORKAPaul T QuinlanGeneral Counsel733$41.30$6.1B-20.03%+529.94%$30.3K-2.26%Stalk
Mar 16, 2026SellORKALawrence Otto KleinChief Executive Officer1,729$41.30$6.1B-20.03%+529.94%$71.4K-0.19%Stalk
Mar 16, 2026SellORKAJoana GoncalvesChief Medical Officer14,641$24.85$6.1B-20.03%+529.94%$363.8K-0.10%10b5-1Stalk
Mar 2, 2026SellORKALaura Lee SandlerChief Operating Officer10,000$20.68$6.1B-20.03%+529.94%$206.8K+0.00%10b5-1Stalk
Feb 17, 2026SellORKAJoana GoncalvesChief Medical Officer14,000$19.84$6.1B-20.03%+529.94%$277.8K+0.00%10b5-1Stalk
Jan 15, 2026SellORKAJoana GoncalvesChief Medical Officer14,000$19.57$6.1B-20.03%+529.94%$273.9K+0.00%10b5-1Stalk
Jan 2, 2026SellORKALaura Lee SandlerChief Operating Officer18,000$22.77$6.1B-20.03%+529.94%$409.8K-0.85%10b5-1Stalk
Dec 19, 2025SellORKAJoana GoncalvesChief Medical Officer14,000$18.97$6.1B-20.03%+529.94%$265.5K+0.00%10b5-1Stalk